Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead ...